EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Validation of scores of PRO‐C3 to predict liver‐related events in alcohol‐related liver disease

Stine Johansen iD, Mads Israelsen iD, Ida F Villesen iD, Nikolaj Torp iD, Mette J Nielsen iD, Maria Kjaergaard iD, Katrine P Lindvig iD, Camilla D Hansen iD, Peter Andersen, Ditlev N Rasmussen iD, Sönke Detlefsen iD, Diana J Leeming iD und 4 weitere

Liver International · 2023

DOI: 10.1111/liv.15595 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Liver International, 2023. Verfasst von Stine Johansen und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology, Fibrosis, Fatty Liver and Steatohepatitis Research Center Odense (FLASH), Odense University Hospital, …. Hauptthemen laut MEDLINE: Camelids, New World, Non-alcoholic Fatty Liver Disease. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Horizon 2020 Framework Programme, Novo Nordisk Fonden, Odense Universitetshospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aims Risk prediction in alcohol‐related liver disease (ArLD) is an unmet need. We aimed to assess PRO‐C3 models to predict liver‐related events (LRE) in patients with a history of excessive alcohol use without an established diagnosis of chronic liver disease.

Methods

A prospective cohort study of 462 patients with ArLD, split into a derivation cohort of 221 secondary care patients and a validation cohort of 241 primary care patients. Baseline variables, including fibrogenesis marker PRO‐C3, were used to develop a prediction model. Prognostic accuracy was compared to enhanced liver fibrosis (ELF), fibrosis‐4‐index (FIB‐4), transient elastography (TE) and ADAPT.

Results

In the derivation and validation cohorts, 67 (30%) and 19 (8%) experienced an LRE during a median follow‐up of 5.2 years (IQR: 3.2‐6.8) and 4.0 years (IQR: 2.7‐5.6). On top of PRO‐C3 and ADAPT score, we generated a model (ALPACA) of independent predictors of LREs (PRO‐C3, AST/ALT, platelets). ALPACA had high prognostic accuracy with a C ‐statistic of 0.85 in the derivation cohort, comparable to ELF (0.83) and TE (0.84) and significantly higher than FIB‐4 (0.78), PRO‐C3 (0.80) and ADAPT (0.81). In the validation cohort, all tests had comparable C ‐statistics. Compared to low‐risk patients (ALPACA ≤11), high‐risk patients (>11) had a subhazard ratio for LREs of 12.6 (95% CI 5.9‐26.8, p < .001) and higher cumulative incidence (57% vs. 7%, p < .001; derivation cohort). We observed similar subhazard ratio in the validation cohort.

Conclusions

PRO‐C3‐based scores are reliable tools to predict LREs in ArLD patients and are suitable for risk stratification in primary and secondary care.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Camelids, New WorldNon-alcoholic Fatty Liver DiseaseHumansAnimalsComplement C3Prospective StudiesLiverLiver Cirrhosis

Stichwörter der Autor:innen

alcoholic liver diseasebiomarkersextracellular matrixfibrosisprognosis

Substanzen

Complement C3

Autor:innen und Institutionen

  • Department of Gastroenterology and Hepatology, Fibrosis, Fatty Liver and Steatohepatitis Research Center Odense (FLASH), Odense University Hospital, Odense, Denmark.
  • Department of Clinical Research, Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark.
  • Nordic Bioscience A/S, Herlev Hovedgade, Herlev, Denmark.
  • Department of Pathology, Odense University Hospital, Odense, Denmark.
  • Department of Molecular Medicine, Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark.

ORCID-Profile: Stine Johansen, Mads Israelsen, Ida F Villesen, Nikolaj Torp, Mette J Nielsen, Maria Kjaergaard, Katrine P Lindvig, Camilla D Hansen, Ditlev N Rasmussen, Sönke Detlefsen, Diana J Leeming, Maja Thiele, Morten Karsdal, Aleksander Krag

Förderung

  • Horizon 2020 Framework Programme
  • Novo Nordisk Fonden
  • Odense Universitetshospital
  • Siemens
  • Syddansk Universitet
  • Toyota Foundation

Zitieren

APA

Johansen, S., Israelsen, M., Villesen, I. F., Torp, N., Nielsen, M. J., Kjaergaard, M., Lindvig, K. P., Hansen, C. D., Andersen, P., Rasmussen, D. N., Detlefsen, S., Leeming, D. J., Thiele, M., Karsdal, M., Krag, A., & GALAXY and MicrobLiver consortia (2023). Validation of scores of PRO‐C3 to predict liver‐related events in alcohol‐related liver disease. Liver International. https://doi.org/10.1111/liv.15595

Vancouver

Johansen S, Israelsen M, Villesen IF, Torp N, Nielsen MJ, Kjaergaard M, et al. Validation of scores of PRO‐C3 to predict liver‐related events in alcohol‐related liver disease. Liver International. 2023. doi:10.1111/liv.15595

BibTeX
@article{Johansen2023,
  author = {Johansen, Stine and Israelsen, Mads and Villesen, Ida F and Torp, Nikolaj and Nielsen, Mette J and Kjaergaard, Maria and Lindvig, Katrine P and Hansen, Camilla D and Andersen, Peter and Rasmussen, Ditlev N and Detlefsen, Sönke and Leeming, Diana J and Thiele, Maja and Karsdal, Morten and Krag, Aleksander and GALAXY and MicrobLiver consortia, GALAXY and MicrobLiver consortia},
  title = {Validation of scores of PRO‐C3 to predict liver‐related events in alcohol‐related liver disease},
  journal = {Liver International},
  year = {2023},
  doi = {10.1111/liv.15595}
}
Kostenlos starten →